Detalhe da pesquisa
1.
Trends in the prevalence, incidence and survival of non-Hodgkin lymphoma subtypes during the 21st century - a Swedish lymphoma register study.
Br J Haematol
; 189(6): 1083-1092, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32065396
2.
Association of early disease progression and very poor survival in the GALLIUM study in follicular lymphoma: benefit of obinutuzumab in reducing the rate of early progression.
Haematologica
; 104(6): 1202-1208, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30573503
3.
Evaluating the implementation and use of the regional cancer plan in Western Sweden through concept mapping.
Int J Qual Health Care
; 31(7): 44-52, 2019 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30576515
4.
Expression of ribosomal and actin network proteins and immunochemotherapy resistance in diffuse large B cell lymphoma patients.
Br J Haematol
; 181(6): 770-781, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29767447
5.
Molecular Monitoring after Autologous Stem Cell Transplantation and Preemptive Rituximab Treatment of Molecular Relapse; Results from the Nordic Mantle Cell Lymphoma Studies (MCL2 and MCL3) with Median Follow-Up of 8.5 Years.
Biol Blood Marrow Transplant
; 23(3): 428-435, 2017 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-28039078
6.
15-year follow-up of the Second Nordic Mantle Cell Lymphoma trial (MCL2): prolonged remissions without survival plateau.
Br J Haematol
; 175(3): 410-418, 2016 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-27378674
7.
Real world data on primary treatment for mantle cell lymphoma: a Nordic Lymphoma Group observational study.
Blood
; 124(8): 1288-95, 2014 Aug 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-24859361
8.
Nordic MCL3 study: 90Y-ibritumomab-tiuxetan added to BEAM/C in non-CR patients before transplant in mantle cell lymphoma.
Blood
; 123(19): 2953-9, 2014 May 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-24652994
9.
Association of early disease progression and very poor survival in the GALLIUM study in follicular lymphoma: benefit of obinutuzumab in reducing the rate of early progression.
Haematologica
; 105(5): 1465, 2020 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-32358081
10.
Nordic MCL2 trial update: six-year follow-up after intensive immunochemotherapy for untreated mantle cell lymphoma followed by BEAM or BEAC + autologous stem-cell support: still very long survival but late relapses do occur.
Br J Haematol
; 158(3): 355-62, 2012 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-22640180
11.
The Mantle Cell Lymphoma International Prognostic Index (MIPI) is superior to the International Prognostic Index (IPI) in predicting survival following intensive first-line immunochemotherapy and autologous stem cell transplantation (ASCT).
Blood
; 115(8): 1530-3, 2010 Feb 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-20032504
12.
Quality of life, physical function and MRI T2* in elderly low-risk MDS patients treated to a haemoglobin level of ≥120 g/L with darbepoetin alfa ± filgrastim or erythrocyte transfusions.
Eur J Haematol
; 87(3): 244-52, 2011 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-21623919
13.
Proteomic analysis in diffuse large B-cell lymphoma identifies dysregulated tumor microenvironment proteins in non-GCB/ABC subtype patients.
Leuk Lymphoma
; 62(10): 2360-2373, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34114929
14.
Detailed Long-Term Follow-Up of Patients Who Relapsed After the Nordic Mantle Cell Lymphoma Trials: MCL2 and MCL3.
Hemasphere
; 5(1): e510, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-33364550
15.
High immunohistochemical expression of p-AKT predicts inferior survival in patients with diffuse large B-cell lymphoma treated with immunochemotherapy.
Br J Haematol
; 149(4): 560-8, 2010 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-20201946
16.
Long-term progression-free survival of mantle cell lymphoma after intensive front-line immunochemotherapy with in vivo-purged stem cell rescue: a nonrandomized phase 2 multicenter study by the Nordic Lymphoma Group.
Blood
; 112(7): 2687-93, 2008 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-18625886
17.
TBLR1 and CREBBP as potential novel prognostic immunohistochemical biomarkers in diffuse large B-cell lymphoma.
Leuk Lymphoma
; 61(11): 2595-2604, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32546039
18.
Serum biomarkers for atrophic gastritis and antibodies against Helicobacter pylori in the elderly: Implications for vitamin B12, folic acid and iron status and response to oral vitamin therapy.
Scand J Gastroenterol
; 43(9): 1050-6, 2008.
Artigo
em Inglês
| MEDLINE | ID: mdl-18609169
19.
Expression of CD68+ tumor-associated macrophages in patients with diffuse large B-cell lymphoma and its relation to prognosis.
Pathol Int
; 58(8): 529-32, 2008 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-18705775
20.
The expression of NK cell inhibitory receptors on cytotoxic T cells in B-cell chronic lymphocytic leukaemia (B-CLL).
Ann Hematol
; 86(2): 89-94, 2007 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-17043777